Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Maintenance Notification: On Saturday January 19th 2019 you will not be able to log into this website due to planned maintenance work.

If you have any questions or concerns, please feel free to reach out to your support team at clientservices@pharma.informa.com

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Consumer OTC Drugs

NCCAM Omega-3 Fatty Acids Study To Commence In April

This article was originally published in The Tan Sheet

20 Mar 2000
News

The Tan Sheet

Executive Summary

The National Institutes of Health is sponsoring several clinical trials on omega-3 fatty acids, including one investigating their effect on major depression and bipolar disorder and another studying fatty acids' antiarrhythmic effects.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

Industries
Consumer
Subjects
OTC Drugs

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Consumer OTC Drugs

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS090997

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS090997

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

NCCAM Omega-3 Fatty Acids Study To Commence In April

News

Executive Summary

Related Content

Omega-3 studies

Omega-3 studies

Omega-3 studies

Qualified Omega-3 Fatty Acid Health Claim Proposed By Industry Group

NIMH St. John's wort trial, using Lichtwer Pharma product, to begin in October.

NIMH St. John's wort trial, using Lichtwer Pharma product, to begin in October.

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert